BackBotanix Pharmaceuticals Limited Overview

Botanix Pharmaceuticals Limited Net Tangible Assets

Botanix Pharmaceuticals Limited's net tangible assets is $63M.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$63.43M
↓ 21.98% YoYΔ $-17.87M vs prior year quarter

Peer trimmed avg / median

Loading

Botanix Pharmaceuticals Limited Net Tangible Assets History

Loading

Botanix Pharmaceuticals Limited vs. peers: Net Tangible Assets Comparison

Loading

Botanix Pharmaceuticals Limited Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Botanix Pharmaceuticals Limited (BXPHF) FAQ

Botanix Pharmaceuticals Limited (BXPHF) currently reports a net tangible assets of $63M as of June 2026. That compares with $81M in the prior-year period — down 22.0% year over year. Use the charts on this page to explore Botanix Pharmaceuticals Limited's net tangible assets history and peer comparisons.

Botanix Pharmaceuticals Limited's net tangible assets decreased from $81M to $63M — a 22.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Botanix Pharmaceuticals Limited reported $63M in net tangible assets as of June 2026. That compares with $81M in the prior-year period — down 22.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $63M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Botanix Pharmaceuticals Limited, and consider following BXPHF for alerts when major investors trade the stock.

Botanix Pharmaceuticals Limited is classified in the Healthcare sector. On net tangible assets, it currently shows $63M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BXPHF with unrelated industries.